The knowledge about flu and the flu shot is insufficiently available among both patients from the target group and GPs. This is shown in a study commissioned by the Dutch Influenza Foundation and vaccine developer Sanofi Pasteur (one of the two suppliers on the Dutch market). The consequences for public health are significant.
A striking conclusion to it
Premium
Would you like to read this article?
Take Zorgvisie.nl a free trial for a month. The subscription ends automatically after one month.
